Law Ministry directs Ahmedabad Court to deliver US SEC summons to Gautam Adani in bribery case: Report

The Union Law Ministry has forwarded a summon from the US Securities and Exchange Commission (SEC) to an Ahmedabad court for service to industrialist Gautam Adani. This action, reported by The Hindu, was conducted under the Hague Convention on Service of Judicial and Extrajudicial Documents in Civil and Commercial Matters, 1965. The summons, concerning allegations of securities fraud and a $265 million bribery scheme, was forwarded to the Ahmedabad sessions court in February to be served at Adani’s local address.

ALSO READUS SEC seeks Indian govt’s help in Gautam Adani fraud probe

SEC lawsuit and allegations 

The SEC, collaborating with federal prosecutors in the Eastern District of New York, has initiated legal proceedings against Gautam Adani and his nephew Sagar Adani. Both, in their roles as executives of Adani Green Ltd, are accused of concealing substantial bribes to Indian government officials to secure above-market energy contracts. The contracts allegedly benefited Adani Green and Azure Power, a solar energy operator. The lawsuit is currently pending at the US District Court for the Eastern District of New York.

ALSO READAdani Group’s tax payments surge 25% to Rs 58,104 crore in FY 2023-24

Legal Process under Hague Convention 

India, as a signatory to the Hague Convention, is obligated to assist in serving legal documents on residents if requested by another signatory nation like the US. The Department of Legal Affairs (DLA), operating under the Union Law Ministry, initially declined to confirm receipt of the SEC’s request in response to an RTI filed by The Hindu on February 19. However, the DLA later acknowledged that by February 21, it had not received the request, though the summons had been forwarded to the Gujarat court by February 25.

ALSO READ‘Every Indian is mine’, PM Modi replies to a question on Adani bribery charges in US

Adani Group’s response 

Despite the ongoing legal proceedings, the Adani Group appears optimistic about future business prospects in the US. Reports suggest that the company is banking on the new US administration under President Donald Trump, which has reportedly paused enforcement of the Foreign Corrupt Practices Act (FCPA), 1977. The Financial Times noted that Adani Group has resumed exploring business opportunities in the US,

 » Read More

Related Articles

Zydus Lifesciences – Will it succeed in aggressively moving up the value chain?

By Amriteshwar Mathur Zydus Lifesciences is attempting to move up the value chain in the global pharma industry with its expanding focus on the medical technology segment. As part of the above strategy, Zydus Lifesciences has made a foray in the higher margin orthopedic products segment with an acquisition of 85.6% stake in France-based Amplitude

Two chemical stocks indicating strength and reversal

By Kiran Jani The chemical sector, which has been on a downward trend for the past five months is finally showing signs of a recovery. With prices stabilising and the broader market improving, some stocks are showing potential for a turnaround. HEG and Graphite have formed potential reversal patterns, indicating possible opportunities for traders and

Three auto stocks potentially at bargain buying point

The market has been in a corrective phase for the seventh consecutive month, with many stocks taking a significant dip of 20-40%. After a period of stellar returns between 2020 and 2024, investor expectations were sky-high, but the recent downturn has led to many losing interest in the markets. While these dips have been challenging

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Zydus Lifesciences – Will it succeed in aggressively moving up the value chain?

By Amriteshwar Mathur Zydus Lifesciences is attempting to move up the value chain in the global pharma industry with its expanding focus on the medical technology segment. As part of the above strategy, Zydus Lifesciences has made a foray in the higher margin orthopedic products segment with an acquisition of 85.6% stake in France-based Amplitude

Two chemical stocks indicating strength and reversal

By Kiran Jani The chemical sector, which has been on a downward trend for the past five months is finally showing signs of a recovery. With prices stabilising and the broader market improving, some stocks are showing potential for a turnaround. HEG and Graphite have formed potential reversal patterns, indicating possible opportunities for traders and

Three auto stocks potentially at bargain buying point

The market has been in a corrective phase for the seventh consecutive month, with many stocks taking a significant dip of 20-40%. After a period of stellar returns between 2020 and 2024, investor expectations were sky-high, but the recent downturn has led to many losing interest in the markets. While these dips have been challenging

Is your FD really safe? Know insurance coverage for your deposits with IndusInd and other banks

IndusInd Bank is in the news this week as its stock crashed to a 52-week low (on March 11, 2025) due to an accounting error linked to forex derivative transactions. However, the stock recovered slightly the next day. This financial mess, which might not directly harm ordinary depositors, has once again drawn attention to bank

Baba Ramdev’s Patanjali Ayurved enters insurance sector with majority stake in Magma General Insurance

Baba Ramdev-owned Patanjali Ayurved has expanded its business footprint by acquiring a majority stake in Magma General Insurance. This strategic move marks Patanjali’s entry into the competitive general insurance sector, further diversifying its portfolio beyond its established Ayurvedic, wellness, and consumer goods offerings, reports CNBC TV18. Following the acquisition, Patanjali Ayurved will become the promoter